Biorbis Antibody Engineering and Design Conference and Workshops

Antibody Engineering and Design USA

Accelerating Progress in Antibody Drug Development

Conference: July 28th/29th 2010 | Pre-conference Workshops: July 27th | Boston, Massachusetts, USA

The world's first and only antibody event designed by you...

World leading speakers

speaker photo speaker photo speaker photo
Dr Davinder Gill
Vice President, Global Biologics Technologies Group
Pfizer
Dr Zhenping Zhu
Vice President and Global Head, Protein Sciences
Novartis
Dr William Strohl
Vice President, Biologics Research
Johnson & Johnson
speaker photo speaker photo speaker photo
Dr Robert Beckman
Executive Director, Clinical Research Oncology
Daiichi-Sankyo
Dr Tristan Vaughan
Senior Director, Lead Generation
MedImmune
Dr Chung-Ming Hsieh
Senior Group Leader, Biologics Research
Abbott
speaker photo speaker photo speaker photo
Dr Daniel Lightwood
Senior Group Leader, Antibody Discovery
UCB-Celltech
Dr Robert Kelley
Senior Scientist, Antibody Engineering
Genentech
Dr Vahe Bedian
Director, Biotherapeutics
AstraZeneca
speaker photo speaker photo speaker photo
Dr Randy Brezski
Research Scientist, Fc Engineering
Centocor
Dr Jennifer Michaelson
Principal Scientist, Molecular Discovery
Biogen Idec
Prof Dane Wittrup
Professor of Chemical Engineering and Bioengineering
MIT
speaker photo speaker photo speaker photo
Dr Ira Pastan
Chief, Laboratory of Molecular Biology
NIH
Dr Janice Reichert
Senior Research Fellow, Tufts, Editor-in-Chief
mAbs
Dr Dimiter Dimitrov
Senior Investigator, Protein Interaction Group
NCI
speaker photo speaker photo speaker photo
Dr Jim Mo
Research Fellow, Analytical Research and Development
Pfizer
Dr Jijie Gu
Principal Scientist, Biologics Research
Abbott
Dr Linda Engle
Principal Scientist, Discovery
(Adnexus) a BMS company
speaker photo Dr Horacio Nastri, Head, Antibody Technologies, EMD Serono Dr Barbara Rellahan, Principal Investigator, Division of Monoclonal Antibodies
FDA
Dr Ryan Fiorini
Chief Operating Officer
Immunologix
  • Dr Dan Lightwood, Senior Group Leader, Antibody Engineering, UCB-Celltech
  • Dr Ulrich Haupts, Director, Assay Technology and Analytics, Bayer
  • Dr Guna Kannan, Principal Scientist, Protein Science, Amgen
  • Dr Dariusz Janecki, Scientist, Biologics Mass Spectrometry and Allied Technologies, Centocor

The Biorbis Antibody Engineering & Design, USA conference is a new breed of antibody meeting, different to any other you've experienced.

Because it's been designed by you.

It's been designed by people from companies like Genentech, MedImmune, Roche, Abbott, Johnson & Johnson, Biogen Idec, Merck, UCB Celltech, Pfizer and many other big pharmaceutical companies and innovative biotechs.

Why attend?

Shorn of tired case studies and company overviews, the focus is on delivering practical value to your antibody drug development activities.

Covering challenges and opportunities identified by you, you'll leave this meeting with a raft of new ideas and contacts to take back to your organization.

Hear speakers talk about overcoming problems you're facing with a level of frankness and sincerity you can't get from any other antibody event.

Meet innovative scientists and research leaders from big pharma and large biotech, and understand how they meet the challenges associated with engineering and designing more effective antibody drugs.

What's on the agenda?

Here are just some of topics covered on the agenda:

  • Engineering antibodies with enhanced characteristics. Isotype choice, half life, stability, efficacy, immunogenicity, using structural insights and more…
  • Utilizing structural-based drug design. How to enhance structural understanding, epitope mapping and using crystallization studies to improve subsequent development
  • Reduction of manufacturing risk and improving expression early in the development process
  • How to ensure appropriate species cross-reactivity
  • How to improve anti-tumour activity through better antibody design. The thoughts of several of the world's leading oncology experts and case studies
  • Generation of multivalent antibodies and use combinatorial strategies to combat cancer
  • Discovery of suitable antibody candidates and identification new targets via novel strategies
  • Exploiting the potential of immunodrug conjugates as an emerging therapeutic

1-2-1 Partnering

We work harder than any other meeting organizer to put you in front of the individuals you want to meet, providing personal introductions and a host of other networking opportunities including:

  • Speed networking – Meet up to 50 other attendees in a one hour session. Introduce yourself to potential partners, collaborators and clients.
  • Over 8 hours of networking time built into the agenda
  • Innovative masterclasses providing you with the chance to get tailored solutions to the challenges you're facing.
  • Panel discussion – interactive Q&A sessions giving you an opportunity to join the discussion.
Become an official partner
Early Bird
Official Partners Official Partners Official Partners

Sponsorship & Exhibition Opportunities

Sponsoring or exhibiting at the Biorbis Antibody Engineering and Design meeting will give you access to your next clients in an environment focussed on providing solutions to some of the antibody sector's major challenge. Becoming an official partner provides your company with a cost effective opportunity to:

  • Get fantastic exposure for your brand in front of decision makers actively looking for solutions
  • Give you global coverage for your brand before several thousand potential clients
  • Get face-to-face time with some of the world's heaviest investors in technology, equipment and resources

Media Partners

Media Partners Media Partners Media Partners Media Partners Media Partners Media Partners Media Partners Media Partners Media Partners Media Partners Media Partners